Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $108.2 million.

  • Lucid Diagnostics' Shares Outstanding (Weighted Average) rose 11474.53% to $108.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.2 million, marking a year-over-year increase of 11474.53%. This contributed to the annual value of $50.5 million for FY2024, which is 2097.81% up from last year.
  • Latest data reveals that Lucid Diagnostics reported Shares Outstanding (Weighted Average) of $108.2 million as of Q3 2025, which was up 11474.53% from $99.0 million recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Shares Outstanding (Weighted Average) peaked at $108.2 million during Q3 2025, and registered a low of $35.1 million during Q1 2022.
  • For the 4-year period, Lucid Diagnostics' Shares Outstanding (Weighted Average) averaged around $52.0 million, with its median value being $41.9 million (2023).
  • In the last 5 years, Lucid Diagnostics' Shares Outstanding (Weighted Average) surged by 987.03% in 2024 and then soared by 11474.53% in 2025.
  • Lucid Diagnostics' Shares Outstanding (Weighted Average) (Quarter) stood at $36.2 million in 2022, then grew by 15.44% to $41.8 million in 2023, then rose by 20.98% to $50.5 million in 2024, then skyrocketed by 114.14% to $108.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $108.2 million for Q3 2025, versus $99.0 million for Q2 2025 and $68.8 million for Q1 2025.